Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopentene SCHEMBL8950071 | 0.94 | CA2 (0.37) | CA2 | |
| Cyclohexene SCHEMBL9456974 | 0.82 | — | — | |
| Phosphoric Acid SCHEMBL27742219 | 0.79 | TSHR (0.32) | — | |
| Cyclohexane SCHEMBL8949815 | 0.78 | CA2 (0.50) | CA2 | |
| Cyclopentane SCHEMBL8949945 | 0.78 | CA2 (0.50) | CA2 | |
| Cyclopentene SCHEMBL8022284 | 0.76 | — | — | |
| SCHEMBL7790209 | 0.74 | — | — | |
| Ethane SCHEMBL8949825 | 0.71 | CA2 (0.58) | CA2 | |
| Methane SCHEMBL10582767 | 0.71 | — | — | |
| Cyclohexene SCHEMBL3786519 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5574024-A | Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | EBETINO FRANK H (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0298553-B1 | METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM | Norwich Eaton Pharmaceuticals, Inc. (US) | 1992-01-15 | — | — | EP | disclosed |
| EP-0298553-A1 | Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-01-11 | — | — | EP | disclosed |